Brief Research Report
Published on 10 May 2024
Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients
in Pharmacology of Anti-Cancer Drugs
- 3,275 views
- 4 citations
Brief Research Report
Published on 10 May 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 10 May 2024
in Pharmacology of Infectious Diseases
Original Research
Published on 10 May 2024
in Cardiovascular and Smooth Muscle Pharmacology
Systematic Review
Published on 10 May 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 10 May 2024
in Drug Metabolism and Transport
Original Research
Published on 10 May 2024
in Ethnopharmacology
Review
Published on 10 May 2024
in Ethnopharmacology
Clinical Trial
Published on 10 May 2024
in Respiratory Pharmacology
Original Research
Published on 10 May 2024
in Neuropharmacology
Original Research
Published on 10 May 2024
in Translational Pharmacology
Review
Published on 10 May 2024
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 10 May 2024
in ELSI in Science and Genetics
Original Research
Published on 10 May 2024
in Inflammation Pharmacology
Original Research
Published on 10 May 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 10 May 2024
in Respiratory Pharmacology
Review
Published on 10 May 2024
in Ethnopharmacology